Skip to content
healthcare.dev

Regadenoson

NDC 0641-6253, Regadenoson, injection, solution, from Hikma Pharmaceuticals USA Inc..

Product NDC
0641-6253
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215827
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6253 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REGADENOSON ANHYDROUS.08 mg/mL

Pharmacologic classes

Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]

Package NDCNDC-11Package
0641-6253-01006416253011 SYRINGE, PLASTIC in 1 CARTON (0641-6253-01) / 5 mL in 1 SYRINGE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9e48b407-1ce3-461d-b48e-de183802de25
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0641-6253

Use it

Look up 0641-6253 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6253 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0641-6253. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.